Phibro Animal Health (PAHC) Stock Price, News & Analysis

Company Overview

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.

Key Stats

• Today's Range: $20.73 to $21.63
• 50-Day Range: $20.05 to $25.27
• 52-Week Range: $10.03 to $25.98
• Volume: 191,259 shs
• Average Volume: 143,154 shs
• Market Capitalization: $871.16 million
• P/E Ratio: 50.02
• Dividend Yield: 2.23%
• Price Target: $20.50
• Consensus Rating: Reduce

Phibro Animal Health Stock Analysis - MarketRank™

Phibro Animal Health scored higher than 85% of companies evaluated by MarketBeat, and ranked 174th out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.8 / 5
• Analyst Rating: Reduce

Consensus Rating

Phibro Animal Health has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no buy ratings, 2 hold ratings, and 2 sell ratings.

Amount of Analyst Coverage

Phibro Animal Health has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 4.4 / 5
• Proj. Earnings Growth: 18.52%

Earnings Growth

Earnings for Phibro Animal Health are expected to grow by 18.52% in the coming year, from $1.62 to $1.92 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Phibro Animal Health is 50.02, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 111.77.

Price to Earnings Ratio vs. Sector

The P/E ratio of Phibro Animal Health is 50.02, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 88.83.

Price to Earnings Growth Ratio

Phibro Animal Health has a PEG Ratio of 0.53. PEG Ratios below 1 indicate that a company could be undervalued.

Price to Book Value per Share Ratio

Phibro Animal Health has a P/B Ratio of 3.39. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.79% of the float of Phibro Animal Health has been sold short.

Short Interest Ratio / Days to Cover

Phibro Animal Health has a short interest ratio ("days to cover") of 4.1.

Change versus previous month

Short interest in Phibro Animal Health has recently decreased by 1.73%, indicating that investor sentiment is improving.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Phibro Animal Health pays a meaningful dividend of 2.31%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Phibro Animal Health does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Phibro Animal Health is 111.63%. Payout ratios above 75% are not desirable because they may not be sustainable.

Dividend Sustainability

Based on earnings estimates, Phibro Animal Health will have a dividend payout ratio of 25.00% next year. This indicates that Phibro Animal Health will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 1.1 / 5
• Environmental Score: -3.93

Percentage of Shares Shorted

3.79% of the float of Phibro Animal Health has been sold short.

Short Interest Ratio / Days to Cover

Phibro Animal Health has a short interest ratio ("days to cover") of 4.1.

Change versus previous month

Short interest in Phibro Animal Health has recently decreased by 1.73%, indicating that investor sentiment is improving.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: 0.79

News Sentiment

Phibro Animal Health has a news sentiment score of 0.79. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.63 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 5 news articles for Phibro Animal Health this week, compared to 3 articles on an average week.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Phibro Animal Health insiders have not sold or bought any company stock.

Percentage Held by Insiders

50.07% of the stock of Phibro Animal Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

99.34% of the stock of Phibro Animal Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

PAHC Stock Analysis - Frequently Asked Questions

How have PAHC shares performed this year?

Phibro Animal Health's stock was trading at $21.00 at the beginning of the year. Since then, PAHC stock has increased by 2.4% and is now trading at $21.51.
View the best growth stocks for 2025 here.

How were Phibro Animal Health's earnings last quarter?

Phibro Animal Health Co. (NASDAQ:PAHC) posted its quarterly earnings data on Wednesday, November, 6th. The company reported $0.35 earnings per share for the quarter, beating analysts' consensus estimates of $0.23 by $0.12. The firm earned $260.40 million during the quarter, compared to analysts' expectations of $277.76 million. Phibro Animal Health had a trailing twelve-month return on equity of 21.59% and a net margin of 1.67%.

Who are Phibro Animal Health's major shareholders?

Top institutional shareholders of Phibro Animal Health include Inspire Investing LLC (0.09%) and SG Americas Securities LLC (0.03%).
View institutional ownership trends.

How do I buy shares of Phibro Animal Health?

Shares of PAHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Phibro Animal Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Phibro Animal Health investors own include Solid Power (SLDP), Meta Platforms (META), Tesla (TSLA), JPMorgan Chase & Co. (JPM), NVIDIA (NVDA), AT&T (T) and Advanced Micro Devices (AMD).

Company Calendar

• Last Earnings: 8/31/2023
• Ex-Dividend for 12/18 Dividend: 11/27/2024
• Dividend Payable: 12/18/2024
• Today: 1/21/2025
• Next Earnings (Estimated): 2/05/2025
• Fiscal Year End: 6/30/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:PAHC
• CUSIP: N/A
• CIK: 1069899
• Web: www.pahc.com
• Phone: (201) 329-7300
• Fax: 201-329-7399
• Employees: 1,940
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $20.50
• High Stock Price Target: $25.00
• Low Stock Price Target: $15.00
• Potential Upside/Downside: -3.9%
• Consensus Rating: Reduce
• Rating Score (0-4): 1.50
• Research Coverage: 4 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $0.43
• Trailing P/E Ratio: 49.62
• Forward P/E Ratio: 13.17
• P/E Growth: 0.53
• Net Income: $2.42 million
• Net Margins: 1.67%
• Pretax Margin: 3.11%
• Return on Equity: 21.59%
• Return on Assets: 5.85%

Debt

• Debt-to-Equity Ratio: 1.81
• Current Ratio: 3.23
• Quick Ratio: 1.69

Sales & Book Value

• Annual Sales: $1.02 billion
• Price / Sales: 0.85
• Cash Flow: $2.17 per share
• Price / Cash Flow: 9.85
• Book Value: $6.34 per share
• Price / Book: 3.37

Miscellaneous

• Outstanding Shares: 40,500,000
• Free Float: 20,223,000
• Market Cap: $864.07 million
• Optionable: Optionable
• Beta: 0.53